Teri Ardleigh Swift
Profile
Teri Ardleigh Swift is the founder of Tyrogenex, Inc. She previously worked as a Principal at BioCatalyst Yorkton, Inc.
Former positions of Teri Ardleigh Swift
| Companies | Position | End |
|---|---|---|
| BioCatalyst Yorkton, Inc. | Corporate Officer/Principal | - |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Founder | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
| BioCatalyst Yorkton, Inc. | |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- Teri Ardleigh Swift
